<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/1999/REC-html401-19991224/loose.dtd">
<html><head><title>Report for cutaneous-no_benefit 1440013494897 [GSEA]</title><link href='xtools.css' rel='stylesheet'><link href='http://www.broadinstitute.org/gsea/images/XBench.gif' rel='shortcut icon'></head><body><div class='richTable'><table cols='11' border='1'><th class='richTable'></th><th class='richTable'>GS<br> follow link to MSigDB</th><th class='richTable'>GS DETAILS</th><th class='richTable'>SIZE</th><th class='richTable'>ES</th><th class='richTable'>NES</th><th class='richTable'>NOM p-val</th><th class='richTable'>FDR q-val</th><th class='richTable'>FWER p-val</th><th class='richTable'>RANK AT MAX</th><th class='richTable'>LEADING EDGE</th><tr><td class='lessen'>1</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION'>HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION</a></td><td><a href='HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION.html'>Details ...</a></td><td>158</td><td>-0.40</td><td>-1.77</td><td>0.000</td><td>0.011</td><td>0.021</td><td>3950</td><td>tags=47%, list=28%, signal=65%</td></tr><tr><td class='lessen'>2</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_UV_RESPONSE_DN'>HALLMARK_UV_RESPONSE_DN</a></td><td><a href='HALLMARK_UV_RESPONSE_DN.html'>Details ...</a></td><td>127</td><td>-0.36</td><td>-1.58</td><td>0.001</td><td>0.056</td><td>0.212</td><td>4421</td><td>tags=47%, list=32%, signal=68%</td></tr><tr><td class='lessen'>3</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_TGF_BETA_SIGNALING'>HALLMARK_TGF_BETA_SIGNALING</a></td><td><a href='HALLMARK_TGF_BETA_SIGNALING.html'>Details ...</a></td><td>51</td><td>-0.39</td><td>-1.45</td><td>0.045</td><td>0.137</td><td>0.574</td><td>4314</td><td>tags=45%, list=31%, signal=65%</td></tr><tr><td class='lessen'>4</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_NOTCH_SIGNALING'>HALLMARK_NOTCH_SIGNALING</a></td><td><a href='HALLMARK_NOTCH_SIGNALING.html'>Details ...</a></td><td>29</td><td>-0.41</td><td>-1.35</td><td>0.095</td><td>0.253</td><td>0.889</td><td>2601</td><td>tags=34%, list=19%, signal=42%</td></tr><tr><td class='lessen'>5</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_MITOTIC_SPINDLE'>HALLMARK_MITOTIC_SPINDLE</a></td><td><a href='HALLMARK_MITOTIC_SPINDLE.html'>Details ...</a></td><td>196</td><td>-0.29</td><td>-1.30</td><td>0.041</td><td>0.303</td><td>0.966</td><td>4546</td><td>tags=37%, list=33%, signal=54%</td></tr><tr><td class='lessen'>6</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_MYC_TARGETS_V2'>HALLMARK_MYC_TARGETS_V2</a></td><td><a href='HALLMARK_MYC_TARGETS_V2.html'>Details ...</a></td><td>58</td><td>-0.32</td><td>-1.20</td><td>0.189</td><td>0.550</td><td>1.000</td><td>1473</td><td>tags=17%, list=11%, signal=19%</td></tr><tr><td class='lessen'>7</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_MYOGENESIS'>HALLMARK_MYOGENESIS</a></td><td><a href='HALLMARK_MYOGENESIS.html'>Details ...</a></td><td>118</td><td>-0.28</td><td>-1.20</td><td>0.148</td><td>0.486</td><td>1.000</td><td>4763</td><td>tags=47%, list=34%, signal=71%</td></tr><tr><td class='lessen'>8</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_CHOLESTEROL_HOMEOSTASIS'>HALLMARK_CHOLESTEROL_HOMEOSTASIS</a></td><td><a href='HALLMARK_CHOLESTEROL_HOMEOSTASIS.html'>Details ...</a></td><td>67</td><td>-0.29</td><td>-1.13</td><td>0.260</td><td>0.638</td><td>1.000</td><td>3626</td><td>tags=36%, list=26%, signal=48%</td></tr><tr><td class='lessen'>9</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_WNT_BETA_CATENIN_SIGNALING'>HALLMARK_WNT_BETA_CATENIN_SIGNALING</a></td><td><a href='HALLMARK_WNT_BETA_CATENIN_SIGNALING.html'>Details ...</a></td><td>35</td><td>-0.32</td><td>-1.10</td><td>0.321</td><td>0.679</td><td>1.000</td><td>4526</td><td>tags=40%, list=32%, signal=59%</td></tr><tr><td class='lessen'>10</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_UNFOLDED_PROTEIN_RESPONSE'>HALLMARK_UNFOLDED_PROTEIN_RESPONSE</a></td><td><a href='HALLMARK_UNFOLDED_PROTEIN_RESPONSE.html'>Details ...</a></td><td>107</td><td>-0.26</td><td>-1.09</td><td>0.291</td><td>0.640</td><td>1.000</td><td>3478</td><td>tags=31%, list=25%, signal=41%</td></tr><tr><td class='lessen'>11</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_APICAL_JUNCTION'>HALLMARK_APICAL_JUNCTION</a></td><td><a href='HALLMARK_APICAL_JUNCTION.html'>Details ...</a></td><td>136</td><td>-0.24</td><td>-1.04</td><td>0.398</td><td>0.765</td><td>1.000</td><td>4702</td><td>tags=38%, list=34%, signal=56%</td></tr><tr><td class='lessen'>12</td><td><a href='http://cancerimmunity.org/peptide/tumor-specific/'>CANCER_IMMUNITY_SHARED_TUMOR_SPECIFIC_ANTIGENS</a></td><td><a href='CANCER_IMMUNITY_SHARED_TUMOR_SPECIFIC_ANTIGENS.html'>Details ...</a></td><td>2</td><td>-0.67</td><td>-1.03</td><td>0.456</td><td>0.709</td><td>1.000</td><td>1559</td><td>tags=50%, list=11%, signal=56%</td></tr><tr><td class='lessen'>13</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_HYPOXIA'>HALLMARK_HYPOXIA</a></td><td><a href='HALLMARK_HYPOXIA.html'>Details ...</a></td><td>160</td><td>-0.22</td><td>-0.98</td><td>0.521</td><td>0.834</td><td>1.000</td><td>2829</td><td>tags=24%, list=20%, signal=30%</td></tr><tr><td class='lessen'>14</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_ANGIOGENESIS'>HALLMARK_ANGIOGENESIS</a></td><td><a href='HALLMARK_ANGIOGENESIS.html'>Details ...</a></td><td>25</td><td>-0.29</td><td>-0.93</td><td>0.582</td><td>0.915</td><td>1.000</td><td>3841</td><td>tags=40%, list=27%, signal=55%</td></tr><tr><td class='lessen'>15</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_MYC_TARGETS_V1'>HALLMARK_MYC_TARGETS_V1</a></td><td><a href='HALLMARK_MYC_TARGETS_V1.html'>Details ...</a></td><td>197</td><td>-0.18</td><td>-0.85</td><td>0.809</td><td>1.000</td><td>1.000</td><td>5282</td><td>tags=39%, list=38%, signal=61%</td></tr><tr><td class='lessen'>16</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_HEME_METABOLISM'>HALLMARK_HEME_METABOLISM</a></td><td><a href='HALLMARK_HEME_METABOLISM.html'>Details ...</a></td><td>153</td><td>-0.19</td><td>-0.85</td><td>0.780</td><td>1.000</td><td>1.000</td><td>2887</td><td>tags=22%, list=21%, signal=27%</td></tr><tr><td class='lessen'>17</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_APICAL_SURFACE'>HALLMARK_APICAL_SURFACE</a></td><td><a href='HALLMARK_APICAL_SURFACE.html'>Details ...</a></td><td>29</td><td>-0.25</td><td>-0.82</td><td>0.737</td><td>1.000</td><td>1.000</td><td>2131</td><td>tags=24%, list=15%, signal=28%</td></tr><tr><td class='lessen'>18</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_HEDGEHOG_SIGNALING'>HALLMARK_HEDGEHOG_SIGNALING</a></td><td><a href='HALLMARK_HEDGEHOG_SIGNALING.html'>Details ...</a></td><td>24</td><td>-0.24</td><td>-0.76</td><td>0.834</td><td>1.000</td><td>1.000</td><td>4963</td><td>tags=46%, list=36%, signal=71%</td></tr><tr><td class='lessen'>19</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_DNA_REPAIR'>HALLMARK_DNA_REPAIR</a></td><td><a href='HALLMARK_DNA_REPAIR.html'>Details ...</a></td><td>136</td><td>-0.17</td><td>-0.74</td><td>0.951</td><td>1.000</td><td>1.000</td><td>3218</td><td>tags=21%, list=23%, signal=27%</td></tr><tr><td class='lessen'>20</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_PI3K_AKT_MTOR_SIGNALING'>HALLMARK_PI3K_AKT_MTOR_SIGNALING</a></td><td><a href='HALLMARK_PI3K_AKT_MTOR_SIGNALING.html'>Details ...</a></td><td>86</td><td>-0.16</td><td>-0.66</td><td>0.969</td><td>1.000</td><td>1.000</td><td>2088</td><td>tags=13%, list=15%, signal=15%</td></tr><tr><td class='lessen'>21</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/HALLMARK_SPERMATOGENESIS'>HALLMARK_SPERMATOGENESIS</a></td><td><a href='HALLMARK_SPERMATOGENESIS.html'>Details ...</a></td><td>64</td><td>-0.15</td><td>-0.59</td><td>0.988</td><td>0.992</td><td>1.000</td><td>2805</td><td>tags=17%, list=20%, signal=21%</td></tr><caption class='table'>Table: Gene sets enriched in phenotype <b>cutaneous-no_benefit (9 samples)<b>&nbsp<a href='gsea_report_for_cutaneous-no_benefit_1440013494897.xls'>[plain text format]</a></caption></table></div><br></body></html>